Plus Therapeutics, Inc. | CYTX - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $12.72M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Baxter International BAX:US USD 1.67B 45M
Cerus CERS:US USD 27.6M 7.98M
Haemonetics HAE:US USD 284.47M 60.46M
Infinity Pharmaceuticals INFI:US USD 25.74M 12.58M
Merrimack Pharmaceuticals MACK:US USD 19.4M 38K
Mirati Therapeutics MRTX:US USD 232.96M 50.74M
Northwest Biotherapeutics NWBO:US USD 6.19M 774K
Plus Therapeutics, Inc. CYTX:US USD 12.72M 5.4M
Starpharma Holdings Ltd SPL:AU AUD 44.04M 5.88M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 2.14B 658M